Back to 
RHUMBLINE ADVISERS
RHUMBLINE ADVISERS
ATHE6 quarters
Position history for RHUMBLINE ADVISERS's holdings in Alterity Therapeutics Ltd
Yes. RhumbLine Advisers holds 2,009 shares of ATHE (Alterity Therapeutics), worth $10,786, as of its Q2 2026 13F filing. It increased the position by 39 shares (+2.0%) from Q1 2026. RhumbLine Advisers has held ATHE since Q1 2025, across 6 quarterly 13F filings.
Current Value
$10,786
Current Shares
2,009
Total Value Change
+$10,336
Total Shares Change
+1,879
Quarter-by-Quarter History
Other major holders of ATHE: Point72 Asset Management, L.P., MORGAN STANLEY, GREENLEAF TRUST, HB Wealth Management, LLC